Rapid Diagnostics Market Research Report Information By Product (Over the Counter (OTC) Kits and Professional Kits), By Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy & Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, and Toxicology Testing), And By Region (North America, Europe, Asia-Pacific, and Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT

6.1. Overview

6.2. Over the Counter (OTC) Kits

6.3. Professional Kits

7. GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION

7.1. Overview

7.2. Blood Glucose Testing

7.3. Infectious Disease Testing

7.4. Cardiometabolic Testing

7.5. Pregnancy & Fertility Testing

7.6. Fecal Occult Blood Testing

7.7. Coagulation Testing

7.8. Toxicology Testing

8. GLOBAL RAPID DIAGNOSTICS MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Rapid Diagnostics Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Rapid Diagnostics Market,

9.7. Key Developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Abaxis

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Becton

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Dickinson & Company

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Bio-Rad Laboratories

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Accriva Diagnostics

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. ACON Laboratories Inc

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Hologic Inc

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Abbott Laboratories

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Roche Diagnostics

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Bayer HealthCare Pharmaceuticals LLC

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Cepheid Inc

10.11.1. Company Overview

10.11.2. Financial Overview

10.11.3. Products Offered

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL RAPID DIAGNOSTICS MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL RAPID DIAGNOSTICS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 US: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 8 US: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 9 CANADA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 10 CANADA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 3 GERMANY: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 FRANCE: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 6 FRANCE: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 ITALY: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 8 ITALY: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 9 SPAIN: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 10 SPAIN: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 11 UK: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 12 UK: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 JAPAN: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 18 JAPAN: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 19 CHINA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 20 CHINA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 21 INDIA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 22 INDIA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 AUSTRALIA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 24 AUSTRALIA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 33 AFRICA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 34 AFRICA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RAPID DIAGNOSTICS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RAPID DIAGNOSTICS MARKET

FIGURE 4 GLOBAL RAPID DIAGNOSTICS MARKET, SHARE (%), BY PRODUCT, 2022

FIGURE 5 GLOBAL RAPID DIAGNOSTICS MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL RAPID DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 ABAXIS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 ABAXIS: SWOT ANALYSIS

FIGURE 14 BECTON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 BECTON: SWOT ANALYSIS

FIGURE 16 DICKINSON & COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 DICKINSON & COMPANY: SWOT ANALYSIS

FIGURE 18 BIO-RAD LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 BIO-RAD LABORATORIES: SWOT ANALYSIS

FIGURE 20 ACCRIVA DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 ACCRIVA DIAGNOSTICS: SWOT ANALYSIS

FIGURE 22 ACON LABORATORIES INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 ACON LABORATORIES INC: SWOT ANALYSIS

FIGURE 24 HOLOGIC INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 HOLOGIC INC: SWOT ANALYSIS

FIGURE 26 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 ABBOTT LABORATORIES: SWOT ANALYSIS

FIGURE 28 ROCHE DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ROCHE DIAGNOSTICS: SWOT ANALYSIS

FIGURE 30 BAYER HEALTHCARE PHARMACEUTICALS LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 BAYER HEALTHCARE PHARMACEUTICALS LLC: SWOT ANALYSIS

FIGURE 32 CEPHEID INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 CEPHEID INC: SWOT ANALYSIS